Prognostic classification of patients with acute lymphoblastic leukemia by using gene copy number profiles identified from array-based comparative genomic hybridization data

Leukemia Research

Volumn 34, Issue 11, 2010, Pages 1476-1482

  Usvasalo, Anu ^a   Elonen, Erkki ^b   Saarinen Pihkala, Ulla M ^a   Räty, Riikka ^b   Harila Saari, Arja ^c   Koistinen, Pirjo ^c   Savolainen, Eeva Riitta ^c   Knuutila, Sakari ^a   Hollmén, Jaakko ^d  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c OULU UNIVERSITY HOSPITAL   (Finland)

^d AALTO UNIVERSITY   (Finland)

Author keywords

Acute lymphoblastic leukemia; Adolescents; Biomarkers; Diagnostic classifier; Gene selection; Microarray CGH

Indexed keywords

BCL2 ANTAGONIST KILLER 1 PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2C; DNA; GLUTATHIONE TRANSFERASE M1; METALLOTHIONEIN 1F; METALLOTHIONEIN I; PROTEIN BAK; UNCLASSIFIED DRUG; BAK1 PROTEIN, HUMAN; CDKN2C PROTEIN, HUMAN; GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE TRANSFERASE; METALLOTHIONEIN; MT1F PROTEIN, HUMAN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER RESISTANCE; CANCER RISK; CHILD; CLASSIFIER; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CYTOSTASIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIPLOIDY; DNA MICROARRAY; FEMALE; FINLAND; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC MODEL; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SELECTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LEUKOCYTE COUNT; LYMPHOCYTE TRANSFORMATION; MALE; MARKER GENE; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; CLASSIFICATION; GENETICS; PROCEDURES; PROGNOSIS; YOUNG ADULT;

ADOLESCENT; ADULT; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; CHILD; CLASSIFICATION; COMPARATIVE GENOMIC HYBRIDIZATION; CYCLIN-DEPENDENT KINASE INHIBITOR P18; GENE DOSAGE; GLUTATHIONE TRANSFERASE; HUMANS; METALLOTHIONEIN; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; RISK ASSESSMENT; YOUNG ADULT;

EID: 77957032517     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2010.02.031     Document Type: Article

References (49)

1. Gustafsson G., Schmiegelow K., Forestier E., Clausen N., Glomstein A., Jonmundsson G., et al. Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Leukemia 2000, 14:2267-2275.
2. Schrappe M., Reiter A., Ludwig W.D., Harbott J., Zimmermann M., Hiddemann W., et al. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. Blood 2000, 95:3310-3322.
3. Moghrabi A., Levy D.E., Asselin B., Barr R., Clavell L., Hurwitz C., Silverman L.B., et al. Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia. Blood 2007, 109:896-904.
4. Linker C., Damon L., Ries C., Navarro W. Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia. J Clin Oncol 2002, 20:2464-2471.
5. Kantarjian H., Thomas D., O'Brien S., Cortes J., Giles F., Jeha S., et al. Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia. Cancer 2004, 101:2788-2801.
6. Thomas X., Boiron J.M., Huguet F., Dombret H., Bradstock K., Vey N., et al. Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial. J Clin Oncol 2004, 22:4075-4086.
7. Rowe J.M., Buck G., Burnett A.K., Chopra R., Wiernik P.H., Richards S.M., et al. Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993. Blood 2005, 106:3760-3767.
8. Smith M., Arthur D., Camitta B., Carroll A.J., Crist W., Gaynon P., et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol 1996, 14:18-24.
9. Verma A., Stock W. Management of adult acute lymphoblastic leukemia: moving toward a risk-adapted approach. Curr Opin Oncol 2001, 13:14-20.
10. Silverman L.B., Sallan S.E. Newly diagnosed childhood acute lymphoblastic leukemia: update on prognostic factors and treatment. Curr Opin Hematol 2003, 10:290-296.
11. Schultz K.R., Pullen D.J., Sather H.N., Shuster J.J., Devidas M., Borowitz M.J., et al. Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG). Blood 2007, 109:926-935.
12. Borowitz M.J., Devidas M., Hunger S.P., Bowman W.P., Carroll A.J., Carroll W.L., et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study. Blood 2008, 111:5477-5485.
13. van Dongen J.J., Seriu T., Panzer-Grumayer E.R., Biondi A., Pongers-Willemse M.J., Corral L., et al. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Lancet 1998, 352:1731-1738.
14. Saarinen-Pihkala U.M., Heilmann C., Winiarski J., Glomstein A., Abrahamsson J., Arvidson J., et al. Pathways through relapses and deaths of children with acute lymphoblastic leukemia: role of allogeneic stem-cell transplantation in Nordic data. J Clin Oncol 2006, 24:5750-5762.
15. Ferrando A.A., Neuberg D.S., Staunton J., Loh M.L., Huard C., Raimondi S.C., et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 2002, 1:75-87.
16. Yeoh E.J., Ross M.E., Shurtleff S.A., Williams W.K., Patel D., Mahfouz R., et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 2002, 1:133-143.
17. Chiaretti S., Li X., Gentleman R., Vitale A., Vignetti M., Mandelli F., et al. Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival. Blood 2004, 103:2771-2778.
18. Kohlmann A., Schoch C., Schnittger S., Dugas M., Hiddemann W., Kern W., et al. Pediatric acute lymphoblastic leukemia (ALL) gene expression signatures classify an independent cohort of adult ALL patients. Leukemia 2004, 18:63-71.
19. Kuiper R.P., Schoenmakers E.F., van Reijmersdal S.V., Hehir-Kwa J.Y., van Kessel A.G., van Leeuwen F.N., et al. High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression. Leukemia 2007, 21:1258-1266.
20. Mullighan C.G., Goorha S., Radtke I., Miller C.B., Coustan-Smith E., Dalton J.D., et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 2007, 446:758-764.
21. Strefford J.C., Worley H., Barber K., Wright S., Stewart A.R., Robinson H.M., et al. Genome complexity in acute lymphoblastic leukemia is revealed by array-based comparative genomic hybridization. Oncogene 2007, 26:4306-4318.
22. Kawamata N., Ogawa S., Zimmermann M., Kato M., Sanada M., Hemminki K., et al. Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray. Blood 2008, 111:776-784.
23. Paulsson K., Cazier J.B., Macdougall F., Stevens J., Stasevich I., Vrcelj N., et al. Microdeletions are a general feature of adult and adolescent acute lymphoblastic leukemia: unexpected similarities with pediatric disease. PNAS 2008, 105:6708-6713.
24. Rabin K.R., Man T.K., Yu A., Folsom M.R., Zhao Y.J., Rao P.H., et al. Clinical utility of array comparative genomic hybridization for detection of chromosomal abnormalities in pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer 2008, 51:171-177.
25. Holleman A., Cheok M.H., den Boer M.L., Yang W., Veerman A.J., Kazemier K.M., et al. Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. N Engl J Med 2004, 351:533-542.
26. Usvasalo A., Raty R., Knuutila S., Vettenranta K., Harila-Saari A., Jantunen E., et al. Acute lymphoblastic leukemia in adolescents and young adults in Finland. Haematologica 2008, 93:1161-1168.
27. Saarinen-Pihkala U.M., Gustafsson G., Carlsen N., Flaegstad T., Forestier E., Glomstein A., et al. Outcome of children with high-risk acute lymphoblastic leukemia (HR-ALL): Nordic results on an intensive regimen with restricted central nervous system irradiation. Pediatr Blood Cancer 2004, 42:8-23.
28. Usvasalo A., Savola S., Raty R., Vettenranta K., Harila-Saari A., Koistinen P., et al. CDKN2A deletions in acute lymphoblastic leukemia of adolescents and young adults: an array CGH study. Leuk Res 2008, 32:1228-1235.
29. Scheinin I., Myllykangas S., Borze I., Bohling T., Knuutila S., Saharinen J. CanGEM: mining gene copy number changes in cancer. Nucleic Acids Res 2008, 36:D830-D835.
30. Swets J.A. Measuring the accuracy of diagnostic systems. Science 1988, 240:1285-1293.
31. Hilgers R.A. Distribution-free confidence bounds for ROC curves. Methods Inf Med 1991, 30:96-101.
32. Good P. Permutation Tests: A Practical Guide to Resampling Methods for Testing Hypothesis 2000, Springer Verlag, New York.
33. Hastie T., Tibshirani R., Friedman J. The Elements of Statistical Learning: Data Mining, Inference, and Prediction 2001, Springer, New York.
34. Moos P.J., Raetz E.A., Carlson M.A., Szabo A., Smith F.E., Willman C., et al. Identification of gene expression profiles that segregate patients with childhood leukemia. Clin Cancer Res 2002, 8:3118-3130.
35. Ross M.E., Zhou X., Song G., Shurtleff S.A., Girtman K., Williams W.K., et al. Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood 2003, 102:2951-2959.
36. Den Boer M.L., van Slegtenhorst M., De Menezes R.X., Cheok M.H., Buijs-Gladdines J.G., Peters S.T., et al. A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study. Lancet Oncol 2009, 10:125-134.
37. Chittenden T., Harrington E.A., O'Connor R., Flemington C., Lutz R.J., Evan G.I., et al. Induction of apoptosis by the Bcl-2 homologue Bak. Nature 1995, 374:733-736.
38. Kiefer M.C., Brauer M.J., Powers V.C., Wu J.J., Umansky S.R., Tomei L.D., et al. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature 1995, 374:736-739.
39. Hannon G.J., Beach D. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 1994, 371:257-261.
40. Iyer L., Ratain M.J. Pharmacogenetics and cancer chemotherapy. Eur J Cancer 1998, 34:1493-1499.
41. Shimoda R., Achanzar W.E., Qu W., Nagamine T., Takagi H., Mori M., et al. Metallothionein is a potential negative regulator of apoptosis. Toxicol Sci 2003, 73:294-300.
42. Jin R., Huang J., Tan P.H., Bay B.H. Clinicopathological significance of metallothioneins in breast cancer. Pathol Oncol Res 2004, 10:74-79.
43. Sauerbrey A., Zintl F., Volm M. Expression of metallothionein in initial and relapsed childhood acute lymphoblastic leukemia. Ann Hematol 1994, 69:111-115.
44. Andersson A., Ritz C., Lindgren D., Eden P., Lassen C., Heldrup J., et al. Microarray-based classification of a consecutive series of 121 childhood acute leukemias: prediction of leukemic and genetic subtype as well as of minimal residual disease status. Leukemia 2007, 21:1198-1203.
45. Cario G., Stanulla M., Fine B.M., Teuffel O., Neuhoff N.V., Schrauder A., et al. Distinct gene expression profiles determine molecular treatment response in childhood acute lymphoblastic leukemia. Blood 2005, 105:821-826.
46. Flotho C., Coustan-Smith E., Pei D., Cheng C., Song G., Pui C.H., et al. A set of genes that regulate cell proliferation predicts treatment outcome in childhood acute lymphoblastic leukemia. Blood 2007, 110:1271-1277.
47. Bhojwani D., Kang H., Menezes R.X., Yang W., Sather H., Moskowitz N.P., et al. Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: a children's oncology group study. J Clin Oncol 2008, 26:4376-4384.
48. Mullighan C.G., Su X., Zhang J., Radtke I., Phillips L.A., Miller C.B., et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med 2009, 360:470-480.
49. Sulong S., Moorman A.V., Irving J.A., Strefford J.C., Konn Z.J., Case M.C., et al. A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroups. Blood 2009, 113:100-107.